211 related articles for article (PubMed ID: 17431700)
1. Brain metabolites in definite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study.
Unrath A; Ludolph AC; Kassubek J
J Neurol; 2007 Aug; 254(8):1099-106. PubMed ID: 17431700
[TBL] [Abstract][Full Text] [Related]
2. Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study.
Rule RR; Suhy J; Schuff N; Gelinas DF; Miller RG; Weiner MW
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5(3):141-9. PubMed ID: 15512902
[TBL] [Abstract][Full Text] [Related]
3. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis.
Pohl C; Block W; Karitzky J; Träber F; Schmidt S; Grothe C; Lamerichs R; Schild H; Klockgether T
Arch Neurol; 2001 May; 58(5):729-35. PubMed ID: 11346367
[TBL] [Abstract][Full Text] [Related]
4. Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI.
Suhy J; Miller RG; Rule R; Schuff N; Licht J; Dronsky V; Gelinas D; Maudsley AA; Weiner MW
Neurology; 2002 Mar; 58(5):773-9. PubMed ID: 11889242
[TBL] [Abstract][Full Text] [Related]
5. Effect of creatine supplementation on metabolite levels in ALS motor cortices.
Vielhaber S; Kaufmann J; Kanowski M; Sailer M; Feistner H; Tempelmann C; Elger CE; Heinze HJ; Kunz WS
Exp Neurol; 2001 Dec; 172(2):377-82. PubMed ID: 11716561
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive evaluation of corticospinal tract metabolites in amyotrophic lateral sclerosis using whole-brain 1H MR spectroscopy.
Govind V; Sharma KR; Maudsley AA; Arheart KL; Saigal G; Sheriff S
PLoS One; 2012; 7(4):e35607. PubMed ID: 22539984
[TBL] [Abstract][Full Text] [Related]
7. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS.
Rooney WD; Miller RG; Gelinas D; Schuff N; Maudsley AA; Weiner MW
Neurology; 1998 Jun; 50(6):1800-5. PubMed ID: 9633731
[TBL] [Abstract][Full Text] [Related]
8. Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy.
Gredal O; Rosenbaum S; Topp S; Karlsborg M; Strange P; Werdelin L
Neurology; 1997 Apr; 48(4):878-81. PubMed ID: 9109871
[TBL] [Abstract][Full Text] [Related]
9. Integrated imaging of [
Ratai EM; Alshikho MJ; Zürcher NR; Loggia ML; Cebulla CL; Cernasov P; Reynolds B; Fish J; Seth R; Babu S; Paganoni S; Hooker JM; Atassi N
Neuroimage Clin; 2018; 20():357-364. PubMed ID: 30112276
[TBL] [Abstract][Full Text] [Related]
10. Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis.
Abe K; Takanashi M; Watanabe Y; Tanaka H; Fujita N; Hirabuki N; Yanagihara T
Neuroradiology; 2001 Jul; 43(7):537-41. PubMed ID: 11512581
[TBL] [Abstract][Full Text] [Related]
11. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings.
Ellis CM; Simmons A; Andrews C; Dawson JM; Williams SC; Leigh PN
Neurology; 1998 Oct; 51(4):1104-9. PubMed ID: 9781537
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements.
Block W; Karitzky J; Träber F; Pohl C; Keller E; Mundegar RR; Lamerichs R; Rink H; Ries F; Schild HH; Jerusalem F
Arch Neurol; 1998 Jul; 55(7):931-6. PubMed ID: 9678310
[TBL] [Abstract][Full Text] [Related]
13. Diffusion tensor MRI and MR spectroscopy in long lasting upper motor neuron involvement in amyotrophic lateral sclerosis.
Lombardo F; Frijia F; Bongioanni P; Canapicchi R; Minichilli F; Bianchi F; Hlavata H; Rossi B; Montanaro D
Arch Ital Biol; 2009 Sep; 147(3):69-82. PubMed ID: 20014653
[TBL] [Abstract][Full Text] [Related]
14. Detecting neuronal dysfunction of hand motor cortex in ALS: A MRSI study.
Wang Y; Li X; Chen W; Wang Z; Xu Y; Luo J; Lin H; Sun G
Somatosens Mot Res; 2017 Mar; 34(1):15-20. PubMed ID: 28114839
[TBL] [Abstract][Full Text] [Related]
15. Progressive Neurochemical Abnormalities in Cognitive and Motor Subgroups of Amyotrophic Lateral Sclerosis: A Prospective Multicenter Study.
Ta D; Ishaque A; Srivastava O; Hanstock C; Seres P; Eurich DT; Luk C; Briemberg H; Frayne R; Genge AL; Graham SJ; Korngut L; Zinman L; Kalra S
Neurology; 2021 Aug; 97(8):e803-e813. PubMed ID: 34426551
[TBL] [Abstract][Full Text] [Related]
16. MR-spectroscopy in metachromatic leukodystrophy: A model free approach and clinical correlation.
Feldmann J; Martin P; Bender B; Laugwitz L; Zizmare L; Trautwein C; Krägeloh-Mann I; Klose U; Groeschel S
Neuroimage Clin; 2023; 37():103296. PubMed ID: 36563646
[TBL] [Abstract][Full Text] [Related]
17. ALS surrogate markers. MRS.
Kalra S; Arnold DL
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():111-4. PubMed ID: 15512889
[TBL] [Abstract][Full Text] [Related]
18. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.
MacKay S; Meyerhoff DJ; Constans JM; Norman D; Fein G; Weiner MW
Arch Neurol; 1996 Feb; 53(2):167-74. PubMed ID: 8639067
[TBL] [Abstract][Full Text] [Related]
19. β-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): the first step towards an experimental model for sporadic ALS.
de Munck E; Muñoz-Sáez E; Miguel BG; Solas MT; Ojeda I; Martínez A; Gil C; Arahuetes RM
Environ Toxicol Pharmacol; 2013 Sep; 36(2):243-255. PubMed ID: 23688553
[TBL] [Abstract][Full Text] [Related]
20. Role of diffusion tensor imaging or magnetic resonance spectroscopy in the diagnosis and disability assessment of amyotrophic lateral sclerosis.
Liu C; Jiang R; Yi X; Zhu W; Bu B
J Neurol Sci; 2015 Jan; 348(1-2):206-10. PubMed ID: 25524526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
